Global Leading Market Research Publisher QYResearch announces the release of its latest report "Lateral Flow Absorbent Pads - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Lateral Flow Absorbent Pads market, including market size, share, demand, industry development status, and forecasts for the next few years. The global market for Lateral Flow Absorbent Pads was estimated to be worth US65millionin2025andisprojectedtoreachUS 90 million by 2032, growing at a CAGR of 4.8% from 2026 to 2032. For lateral flow assay (LFA) manufacturers and point-of-care (POC) diagnostic developers, the critical test strip component challenge is precise: providing a porous, high-capacity absorbent wicking pad (cellulose, glass fiber, or synthetic fiber) placed at the distal end (downstream) of the nitrocellulose membrane, serving as a fluid sink that pulls liquid sample through the membrane and conjugate pad via capillary action, preventing backflow, and absorbing excess/unbound reagents (unbound antibody-gold conjugate, wash buffer, sample diluent) to reduce non-specific background and achieve clean test lines, with consistent absorption rate (flow rate, mL/min), high fluid holding capacity (total volume, determined by pad size) to ensure all sample flows across the capture/control lines, and minimal non-specific binding (blocked with BSA, casein, surfactants, detergents). The solution lies in lateral flow absorbent pads (also called wick pads, absorbent pads, sink pads)—non-woven cellulose (most common, high absorbency, cost-effective), glass fiber, or synthetic (polyester, polypropylene, nylon) fiber matrices, treated (blocking surfactants) and dried before assembly into test strips/sticks/cassettes. Unlike sample pads (sample application/filter), conjugate pads (conjugate reservoir), and nitrocellulose membrane (capture/control lines), absorbent pads function solely to drive capillary flow and collect waste. As POC testing expands (self-testing, pandemic preparedness, home-use assays, decentralized healthcare), the absorbent pad market grows. 【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】 https://www.qyresearch.com/reports/5984787/lateral-flow-absorbent-pads 1. Industry Segmentation by Absorption Volume and Application The Lateral Flow Absorbent Pads market is segmented as below by Type: High Absorption Volume – 48% market share (2025). For high sample volume (100-200 μL whole blood, serum, plasma) or long flow path (competitive assays). Thicker pad (>1mm, longer wicking). Medium Absorption Volume – 32% market share (standard). 50-100 μL sample volume. Most common (pregnancy, infectious disease, cardiac markers). Low Absorption Volume – 20% market share. 20-50 μL small sample (saliva, small volume). Thin pad. By Application – Medical (human diagnostics) leads with 72% market share. Agricultural and Animal Husbandry (veterinary rapid tests) 12% share. Food & Beverage (pathogen, allergen, mycotoxin, adulteration) 8% share. Military and Forensic (drugs-of-abuse (DOA)) 5% share. Others (environmental) 3% share. Key Players – Lateral flow raw material suppliers: Cytiva (Danaher, Whatman, MilliporeSigma), Merck (MilliporeSigma), Ahlstrom (US, fiber-based materials), Axiva (India), Axiflow (Israel). Porex Corporation (porous polymers). AntiTeck (China), Advanced Microdevices (mdi) (India). Asahi Kasei (Japan). Cytodiagnostic (UK). Also: Sartorius, GVS, Lohmann. 2. Technical Challenges: Flow Rate, Backflow Prevention, and Blocking Flow rate control (wetting speed) — Absorbent pad must wick liquid at consistent rate (not too fast, not too slow). Immobilized capture antibody on membrane requires sufficient incubation (binding). Pad porosity, fiber composition, thickness, density. Controlled by material selection, compression. Backflow prevention — Absorbent pad placed in contact with membrane (overlap 1-2mm). Capillary action draws liquid downstream; pad prevents reverse flow (wicking toward sample pad). Pad positioned as sink. Blocking treatment (BSA, casein) — To reduce non-specific binding (avoid absorbing analytes); treated with BSA (bovine serum albumin), casein, Tween-20, PVP, PVA to block protein binding sites. Dried, stored in desiccated environment (humidity 10-20%, moisture barrier packaging). 3. Policy, User Cases & Market Drivers (Last 6 Months, 2025-2026) CLSI POCT12 (2025) (Point-of-care testing) – Validation of test strip performance, absorbent pad included. IVDR (EU) 2017/746 (in vitro diagnostic regulation) (2025) – Class B/C rapid tests. Documentation of absorbent pad (absorption rate, capacity). WHO prequalification (2025) – Malaria/HIV rapid tests: absorbent pad must meet WHO criteria. User Case – Home Pregnancy Test (hCG, urine) — Absorbent pad (cellulose) wicks urine from membrane (test line) into pad. High absorption volume needed (urine sample up to 200μL, pad capacity >500μL). Completed test: test line + control line visible, pad hidden in plastic cassette. User Case – COVID-19 Antigen Rapid Test (Nasal Swab) — 3-4 drops extraction buffer applied to sample pad, flows through conjugate pad, membrane, absorbent pad (medium absorption). Pad drives flow, absorbs waste. 4. Exclusive Observation: Compression for Flow Rate Absorbent pad compressed between housing and membrane to ensure good contact (capillary bridge). Pad thickness and density affects wicking speed. 5. Outlook & Strategic Implications (2026-2032) Through 2032, the lateral flow absorbent pad market will segment: medium absorption (standard, POC) — 55% value, 4-5% CAGR; high absorption (large volume) — 30% value, 5% CAGR; low absorption (small volume) — 15% value, 4-5% CAGR. Key success factors: absorption rate (μL/sec, consistent), total capacity (μL), non-specific binding (<2% of analyte loss), and blocking efficiency (CV <5%). Suppliers who fail to transition from cellulose to treated cellulose/synthetic for low non-specific binding — and who cannot provide customized blocking formulations — will lose lateral flow raw material market share. Contact Us: If you have any queries regarding this report or if you would like further information, please contact us: QY Research Inc. Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States EN: https://www.qyresearch.com E-mail: global@qyresearch.com Tel: 001-626-842-1666(US) JP: https://www.qyresearch.co.jp